Pasithea Therapeutics Corp. (KTTA) Institutional Ownership

Ownership Summary

Pasithea Therapeutics Corp. (NASDAQ:KTTA) currently has 3 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).

• These investors collectively held 1.5% of the company's total shares outstanding in December 2025, down from 7.8% in September 2025.
• Institutional share ownership changed by 52.89% QoQ, while the number of institutional owners saw a decrease of 62.50% YoY.
• Of these 3 institutional investors, 1 increased their holdings in Pasithea Therapeutics, while 1 of them reduced positions, and 1 investors maintained their exposure.
• The aggregate institutional position in Pasithea Therapeutics now stands at 111.99K shares as of December 2025, after investors increased their holdings (up by 38.74K shares quarter on quarter which is up 34.83K shares year over year).
• VANGUARD GROUP INC's holding of 97.67K shares as of December 31, 2025 makes it the primary institutional investor in Pasithea Therapeutics, owning 1.32% of the stock.
• Among the most significant buyers of Pasithea Therapeutics during December 2025 were VANGUARD GROUP INC (43.86K).
• Leading sellers of Pasithea Therapeutics stock in December 2025 included UBS Group AG (5.12K).
• The top 3 institutional holders of Pasithea Therapeutics for the quarter ending December 2025 included VANGUARD GROUP INC (97.67K), UBS Group AG (13.26K), SBI Securities Co., Ltd. (1.05K).